Land of infusion: Health care entrepreneurs explore new territory

Traditionally available primarily in hospitals, infusion therapy has moved into outpatient clinics and even private homes as health insurance providers seek alternative, lower-cost options for their customers. At the same time, the FDA has grown its pipeline of approved infusion drugs, making it easier for patients to get the help they need.

Accordingly, demand for the treatment — which can battle a wide range of autoimmune conditions ranging from cancer and multiple sclerosis to less severe maladies like asthma and Crohn’s disease — is also on the rise.